Shares of The Medicines Company (NASDAQ: MDCO) dropped 14.5% on Thursday following an announcement after the bell on Wednesday that the drugmaker plans to raise $150 million selling convertible notes, with the potential to raise another $22.5 million if the purchaser uses its overage option.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,